© Copyright by HealthHelpZone.com. All rights reserved.
Reduces diagnostic turnaround times from a week to just one day RIYADH, Saudi Arabia, Nov. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has unveiled its state-of-the-art Virtual Pathology Service at the Madinah branch, revolutionizing the field of anatomical pathology through advanced digital technologies. This service dramatically enhances the speed, accuracy, and accessibility of... ❯❯❯
KENT, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Mind Food Body Ltd., led by Hanna Longstaff, The Eating Behaviour Expert, has launched a new range of corporate wellness solutions designed to address one of the most pervasive challenges facing modern workplaces: destructive eating habits. With over 50% of employees struggling with eating behaviours that impact their mental health, focus, and productivity, Hanna’s tailored... ❯❯❯
MARKHAM, Ontario, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of November 2024, representing $0.936 per Common Share on an annualized basis. The dividend will be payable on December 13, 2024 to shareholders of record as at November 29, 2024. The Company's dividends are... ❯❯❯
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune diseaseCARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis (RA) biomarkers, to be incorporated into the AVISE CTD... ❯❯❯
Partners with Oral & Maxillofacial Surgery of Brockton, MassachusettsIRVING, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) – a management services company that exclusively serves premier oral and maxillofacial surgeons – has formed a new partnership with Oral & Maxillofacial Surgery Inc., an oral and maxillofacial surgery (OMS) practice located in Brockton, Massachusetts. The practice has three... ❯❯❯
Significant declines in Alcohol Use Disorder and cigarette smoking – diet, exercise, and sleep habits remain unchangedMen’s unhealthy lifestyle habits in 2024 (67%) have improved since 2017 (72%)On International Men’s Day, November 19: CMHF encourages men to take action and learn their health risks VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- New research from the Canadian Men’s Health Foundation shows a positive... ❯❯❯
Cash balance at $18.5 millionStrengthened leadership team with new members driving stenoparib developmentNASDAQ compliance regained Boston (November 14, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments using its proprietary, drug-specific patient selection technology, today reported financial... ❯❯❯
Advancing hydrogen for medical and industrial usesTORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on molecular hydrogen and AI diagnostics, is pleased to announce it has entered into a collaboration agreement with EIREX, a hydrogen technology company, for the development and commercialization of EIREX’s novel modular... ❯❯❯
NAVIGATE trial on track for top-line results in December 2024 NORCROSS, Ga., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the quarter ended September 30, 2024. Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics, said “This past quarter, we... ❯❯❯
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on molecular hydrogen and AI diagnostics, announces that it has granted an aggregate of 4,500,000 stock options ("Options") to its directors, officers and consultants at a price of $0.05 per common share, expiring five years from the date of grant and vest one-fourth increments... ❯❯❯